Brief: Microbix - Final Laboratory In Second Production Site, At 235 Watline Ave., Is Now Validated To Accommodate Automated And Larger-Scale Manufacturing
Feb 15 (Reuters) - Microbix Biosystems Inc MBX.TO :
* MICROBIX - FINAL LABORATORY IN SECOND PRODUCTION SITE, AT
235
WATLINE AVE., IS NOW VALIDATED TO ACCOMMODATE AUTOMATED AND
LARGER-SCALE MANUFACTURING
* MICROBIX BIOSYSTEMS INC - RENOVATIONS HAVE NOW COMMENCED
AT
MICROBIX'S THIRD SITE, AT 275 WATLINE AVE
Source text for Eikon: ID:nGNX17NtkB
Further company coverage: MBX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbix Biosystems
See all newsCanada's Microbix Q3 revenue rises on higher antigen, QAPs sales
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million